Eye Conditions Eye Tests Myopia Age-related Conditions Eye Care Optometry Color Blindness Eye Diseases Vision Loss Blindness Assistive Technology Cataracts Infections Eye Examinations Retinal Health Eye Protection Ocular Complications Child Vision Problems Driving Safety Eye Safety Visual Fatigue Preventable Blindness Optical Devices Eye Strain Macular Degeneration Therapeutic Innovations Temporary Blindness Double Vision Glare Effects Eye Exams Color Vision Deficiency Impact of Light on Vision Restorative Surgery Common Eye Issues Driver Health Eyewear Nutritional Supplements Corrective Lenses Visual Impairment Eye Testing Blindness Prevention Vision Problems Low Eye Pressure Childhood Myopia Medical Conditions Treatment Options Eye Trauma Protective Equipment Eyewear Solutions Chronic Diseases Age-related Macular Degeneration Pediatric Care Strabismus Blindness Treatments Preventive Measures Eye Infections Vision Care Eye Care Innovations Spaceflight-Associated Neuro-ocular Syndrome Impact of Glare Amblyopia Nearsightedness Vision Enhancement Non-invasive Procedures Retinal Diseases Color Blindness Treatments Colorblindness Eye Health Vision Disorders Cognitive Health Eye Surgery Blindness Treatment Ocular Conditions Assistive Devices Eye Irritation
The offer targets Ixo-vec, a one-time treatment for wet age-related macular degeneration now in a late-stage trial.
